source
- Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billionThe wide-ranging pact involves as many as 13 drugs and marks the latest example of the growing relationship between Chinese pharmaceutical firms and their U.S. and Europe-based counterparts.BioPharma Dive · 2mo ago↗ source
- STAT+: Capsida says it still doesn’t know what caused gene therapy deathSome in the gene therapy field lament lost time while Capsida kept silent about the brain receptor it was targeting when things went wrong.STAT · 2mo ago↗ source
- A year after Vertex’s big launch, pain drug research faces a pivotal momentJournavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?BioPharma Dive